Phae 1: Functionalization reactions
Oxidative pathways |
Reduction |
Hydrolytic reactions |
1. Alcohols & Aldehydes |
1. Aldehydes |
1. Esters |
Ex: pyridoxine becoming pyridoxal |
Become alcohols from H addition. |
Ex: Cocaine, Aspirin, Mepiridine, Procaine |
Aliphatic hydroxylation: addition of OH. |
2. Azo-reduction |
The ester (COO) gp becomes an acid. |
2. Oxidative N-demethylation |
Ex: Sulfasalazine--> Sulfapyridine |
2. Amides |
Ex: Methamphetamine, Lidocaine, Epinephrine |
3. Nitroreduction |
Ex: Procainamide |
N with a CH3 (or other) get replaced by =O |
Ex: Nitrazepam, Chloramphenicol |
3. Glycosides |
3. Oxidative deamination |
NO2 becomes NH2. |
Ex: Digoxin --> Digoxin aglycone |
Ex: Norepinephrine, Histamine, Mescaline |
4. Dehalogenation |
4. Epoxides |
Removal of NH2 and its release as ammonia gas. Gets replaced by =O. |
Ex: Halothane, Ethchlovynol |
Ex: DES metabolite--> DES |
4. Oxidative O-dealkylation |
Ex: Phenacetin, Codeine, Mescaline, Papaverine |
O-alkyl becomes -OH. |
5. N-Oxidation |
Ex: Imipramine. |
Coordinate bond between tert-N and O. |
6. S-Oxidation |
Ex: Chlorpromazine; S-O (sulfoxide) then becomes (S=O) Sulfone. |
7. Desulfuration |
Ex: Thiobarbital, Parathion |
=S is replaced by =O |
8. Epoxidation |
Ex: DES; O in a strained tricyclic structure. |
Phase 1: Functionalisation cont.
Decarboxylation |
Oxidative pathways catalysed by other oxidoreductases |
Reductive pathways by oxidoreductases |
Ex: Histidine, a-methyldopa, L-Dopa. |
Alcohol dehydrogenases |
Less significant |
Removal of carboxylic acid. |
1ry alcohol (benzylalcohol, phenethanol, retinol)--> Aldehydes |
Include reactions on: |
Histidine--> Histamine; L-Dopa--> dopamine. |
2ry alcohols---> Ketones |
1) C=O compounds 2) Olefins 3) Dehalogenation 4) other atoms |
|
3ry alcohols do not react. |
Hydrolytic pathways |
|
Aldehyde dehydrogenases |
include hydrolyses enzymes |
|
Aldehydes--> Acid |
They add a water to functional groups. |
|
Monoamine oxidase (MAO) |
|
Has 2 forms/isozymes A & B, that deaminate catecholamines. |
|
Treats Parkinson's (esp MAO B). |
Phase 2: conjugation reaction
Methylation |
Acetylation & Acylation |
Amino acid conjugation reactions |
A methyl group on carrier (SAM) adds the methyl to O/N/S on the drug or phase 1 metabolite. |
Acyl-coenzyme A is required |
Glycine is used to conjugate COOH gp in xenobiotics. |
O-methylation by COMT. |
Ex: Sulfamethoxazole where COCH3 gp is added. |
Carrier is glycine N-acyltransferase. |
N-methylation by N-methyltransferase. |
Some people are fast or slow acetylators and thus drug dose metabolized here should be adjusted. |
S-methylation by thiol or thiopurine methyltransferases. |
Thiol containing drugs (captopril, mercaptopurine, propylthiouracil) are subjected to S-methylation. |
Captopril is unique in that phase 2 S-methylation occurs first, then phase 1. |
Phase 2: conjugation reaction cont.
Glucuronidation |
Sulfate conjugation |
Glutathione (GSH) conjugation |
Miscellaneous conjugation reactions |
Conjugation with glucuronic acid with carrier UDPG. |
A sulfate molecule is transferred from carrier, PAPS, to the substrate/drug by enzyme cytosolic sulfotransferases. |
In its reduced form, its the tripeptide GSH. But it becomes in the oxidized form GS-SG and the SG attachs to drug |
1) Phosphorylation via phosphotransferase |
The enzyme, UDP-glucouronosyl transferase, acts on O, N, S in the compound. |
|
|
Ex: Zidovudine. |
|
|
|
2) Endogenous carbonyl + Exogenous drug with hydrazines or hydrazides---> Hydrazones. |
|